Trials / Conditions / Thyroid Cancer, Medullary
Thyroid Cancer, Medullary
5 registered clinical trials studyying Thyroid Cancer, Medullary.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer NCT05534594 | University Medical Center Groningen | N/A |
| Completed | 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid C NCT03647657 | University Hospital, Basel, Switzerland | EARLY_Phase 1 |
| Terminated | Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer NCT03630120 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Active Not Recruiting | 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. NCT02088645 | University Hospital, Basel, Switzerland | Phase 1 |
| No Longer Available | 18F-FDOPA PET in Neuroendocrine Tumours NCT02431715 | British Columbia Cancer Agency | — |